{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T05:16:26Z","timestamp":1649135786656},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,6,24]],"date-time":"2012-06-24T00:00:00Z","timestamp":1340496000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00467-012-2234-5","type":"journal-article","created":{"date-parts":[[2012,6,23]],"date-time":"2012-06-23T09:47:22Z","timestamp":1340444842000},"page":"2227-2231","source":"Crossref","is-referenced-by-count":2,"title":["Is cyclophosphamide effective in patients with IgM-positive minimal change disease?"],"prefix":"10.1007","volume":"27","author":[{"given":"Pavel","family":"Geier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amani","family":"Roushdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylva","family":"Sk\u00e1lov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Vethamuthu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabrielle","family":"Weiler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janusz","family":"Feber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,24]]},"reference":[{"key":"2234_CR1","first-page":"610","volume":"38","author":"AH Cohen","year":"1978","unstructured":"Cohen AH, Border WA, Glassock RJ (1978) Nephrotic syndrome with glomerular mesangial IgM deposits. Lab Invest 38:610\u2013619","journal-title":"Lab Invest"},{"key":"2234_CR2","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00467-009-1130-0","volume":"24","author":"SJ Swartz","year":"2009","unstructured":"Swartz SJ, Eldin KW, Hicks MJ, Feig DI (2009) Minimal change disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome. Pediatr Nephrol 24:1187\u20131192","journal-title":"Pediatr Nephrol"},{"key":"2234_CR3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0272-6386(84)80043-8","volume":"3","author":"V Pardo","year":"1984","unstructured":"Pardo V, Riesgo I, Zilleruelo G, Strauss J (1984) The clinical significance of mesangial IgM deposits and mesangial hypercellularity in minimal change nephrotic syndrome. Am J Kidney Dis 3:264\u2013269","journal-title":"Am J Kidney Dis"},{"key":"2234_CR4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ki.1984.14","volume":"25","author":"Y Ji-Yun","year":"1984","unstructured":"Ji-Yun Y, Melvin T, Sibley R, Michael AF (1984) No evidence for a specific role of IgM in mesangial proliferation of idiopathic nephrotic syndrome. Kidney Int 25:100\u2013106","journal-title":"Kidney Int"},{"key":"2234_CR5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/ajkd.2003.50042","volume":"41","author":"J Myllym\u00e4ki","year":"2003","unstructured":"Myllym\u00e4ki J, Saha H, Mustonen J, Helin H, Pasternack A (2003) IgM nephropathy: clinical picture and long-term prognosis. Am J Kidney Dis 41:343\u2013350","journal-title":"Am J Kidney Dis"},{"key":"2234_CR6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/ki.1988.197","volume":"34","author":"WA Border","year":"1998","unstructured":"Border WA (1998) Distinguishing minimal-change disease from mesangial disorders. Kidney Int 34:419\u2013434","journal-title":"Kidney Int"},{"key":"2234_CR7","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0022-3476(82)80632-X","volume":"100","author":"WR Allen","year":"1982","unstructured":"Allen WR, Travis LB, Cavallo T, Brouhard BH, Cunningham RJ (1982) Immune deposits and mesangial hypercellularity in minimal change nephrotic syndrome: clinical relevance. J Pediatr 100:188\u2013191","journal-title":"J Pediatr"},{"key":"2234_CR8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/adc.57.7.544","volume":"57","author":"O Koskimies","year":"1982","unstructured":"Koskimies O, Vilska J, Rapola J, Hallman N (1982) Long-term outcome of primary nephrotic syndrome. Arch Dis Child 57:544\u2013548","journal-title":"Arch Dis Child"},{"key":"2234_CR9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","volume":"362","author":"AA Eddy","year":"2003","unstructured":"Eddy AA, Symons JM (2003) Nephrotic syndrome in childhood. Lancet 362:629\u2013639","journal-title":"Lancet"},{"key":"2234_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000183035","volume":"35","author":"A Tejani","year":"1983","unstructured":"Tejani A, Nicastri AD (1983) Mesangial IgM nephropathy. Nephron 35:1\u20135","journal-title":"Nephron"},{"key":"2234_CR11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/B978-0-323-04883-5.50021-0","volume-title":"Comprehensive pediatric nephrology","author":"EM Hodson","year":"2008","unstructured":"Hodson EM, Alexander SI, Graf N (2008) Steroid-sensitive nephrotic syndrome. In: Geary F, Schaefer F (eds) Comprehensive pediatric nephrology. Mosby, Philadelphia, pp 239\u2013256"},{"key":"2234_CR12","doi-asserted-by":"crossref","unstructured":"Hodson E, Willis N, Craig J (2008) Non-corticosteroid treatment for nephrotic syndrome in children. Cochrane Database Syst Rev 1: CD002290. doi: 10.1002\/14651858.CD002290.pub3","DOI":"10.1002\/14651858.CD002290.pub3"},{"key":"2234_CR13","first-page":"1326","volume":"8","author":"C Ponticelli","year":"1993","unstructured":"Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano R et al (1993) Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial. Nephrol Dial Transplant 8:1326\u20131332","journal-title":"Nephrol Dial Transplant"},{"key":"2234_CR14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s004670000523","volume":"6","author":"K Latta","year":"2001","unstructured":"Latta K, von Schnakenburg C, Ehrich J (2001) A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol 6:271\u2013282","journal-title":"Pediatr Nephrol"},{"key":"2234_CR15","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00467-011-1825-x","volume":"26","author":"A Zagury","year":"2011","unstructured":"Zagury A, de Oliveira AL, de Moraes CAP, de Araujo Montalv\u00e3o JA, Novaes RHLL, de S\u00e1 VM, Monteiro de Carvalho, Dde B, Matuck T (2011) Long-term follow-up after cyclophosphamide therapy in steroid-dependent nephrotic syndrome. Pediatr Nephrol 26:915\u2013920","journal-title":"Pediatr Nephrol"},{"key":"2234_CR16","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00467-011-1830-0","volume":"26","author":"S Azib","year":"2011","unstructured":"Azib S, Macher MA, Kwon T, Dechartres A, Alberti C, Loirat C, Desch\u00eanes G, Baudouin V (2011) Cyclophosphamide in steroid-dependent nephrotic syndrome. Pediatr Nephrol 26:927\u2013932","journal-title":"Pediatr Nephrol"},{"key":"2234_CR17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s004670050224","volume":"11","author":"M Konrad","year":"1997","unstructured":"Konrad M, Mytilineos J, Ruder H, Opelz G, Sch\u00e4rer K (1997) HLA-DR7 predicts the response to alkylating agents in steroid-sensitive nephrotic syndrome. Pediatr Nephrol 11:16\u201319","journal-title":"Pediatr Nephrol"},{"key":"2234_CR18","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00467-010-1717-5","volume":"6","author":"M Husen van","year":"2011","unstructured":"van Husen M, Kemper MJ (2011) New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol 6:881\u2013892","journal-title":"Pediatr Nephrol"},{"key":"2234_CR19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00467-003-1170-9","volume":"18","author":"U Vester","year":"2003","unstructured":"Vester U, Kranz B, Zimmermann S, Hoyer PF (2003) Cyclophosphamide in steroid-sensitive nephrotic syndrome: outcome and outlook. Pediatr Nephrol 18:661\u2013664","journal-title":"Pediatr Nephrol"},{"key":"2234_CR20","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1136\/adc.65.10.1147","volume":"65","author":"N Ueda","year":"1990","unstructured":"Ueda N, Kuno K, Ito S (1990) Eight and 12\u00a0week courses of cyclophosphamide in nephrotic syndrome. Arch Dis Child 65:1147\u20131150","journal-title":"Arch Dis Child"},{"key":"2234_CR21","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/PL00013435","volume":"14","author":"MJ Kemper","year":"2000","unstructured":"Kemper MJ, Altrogge H, Ludwig K, Timmermann K, M\u00fcller-Wiefel DE (2000) Unfavorable response to cyclophosphamide in steroid-dependent nephrotic syndrome. Pediatr Nephrol 14:772\u2013775","journal-title":"Pediatr Nephrol"},{"key":"2234_CR22","first-page":"345","volume":"101","author":"DR Prasad","year":"1997","unstructured":"Prasad DR, Zimmerman SW, Burkholder PM (1997) Immunohistologic features of minimal-change nephrotic syndrome. Arch Pathol Lab Med 101:345\u2013349","journal-title":"Arch Pathol Lab Med"},{"key":"2234_CR23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000167485","volume":"7","author":"J Kopolovic","year":"1987","unstructured":"Kopolovic J, Shvil Y, Pomeranz A, Ron N, Rubinger D, Oren R (1987) IgM nephropathy: morphological study related to clinical findings. Am J Nephrol 7:275\u2013280","journal-title":"Am J Nephrol"},{"key":"2234_CR24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000188804","volume":"72","author":"A Al-Eisa","year":"1996","unstructured":"Al-Eisa A, Carter JE, Lirenman DS, Magil AB (1996) Childhood IgM nephropathy: comparison with minimal change disease. Nephron 72:37\u201343","journal-title":"Nephron"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-012-2234-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-012-2234-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-012-2234-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T21:09:57Z","timestamp":1594328997000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-012-2234-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,24]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2234"],"URL":"https:\/\/doi.org\/10.1007\/s00467-012-2234-5","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,24]]}}}